EE9900092A - PTX-tundlikud G-valgud, nende valmistamine ja kasutamine - Google Patents

PTX-tundlikud G-valgud, nende valmistamine ja kasutamine

Info

Publication number
EE9900092A
EE9900092A EEP199900092A EE9900092A EE9900092A EE 9900092 A EE9900092 A EE 9900092A EE P199900092 A EEP199900092 A EE P199900092A EE 9900092 A EE9900092 A EE 9900092A EE 9900092 A EE9900092 A EE 9900092A
Authority
EE
Estonia
Prior art keywords
ptx
proteins
sensitive
preparation
Prior art date
Application number
EEP199900092A
Other languages
English (en)
Inventor
Siffert Winfried
Original Assignee
Siffert Winfried
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siffert Winfried filed Critical Siffert Winfried
Publication of EE9900092A publication Critical patent/EE9900092A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
EEP199900092A 1996-09-13 1997-08-29 PTX-tundlikud G-valgud, nende valmistamine ja kasutamine EE9900092A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
PCT/EP1997/004709 WO1998011212A1 (de) 1996-09-13 1997-08-29 Ptx-sensitive g-proteine, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
EE9900092A true EE9900092A (et) 1999-10-15

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900092A EE9900092A (et) 1996-09-13 1997-08-29 PTX-tundlikud G-valgud, nende valmistamine ja kasutamine

Country Status (22)

Country Link
US (1) US6251853B1 (et)
EP (1) EP0931145A1 (et)
JP (1) JP2001501811A (et)
KR (1) KR20000036058A (et)
CN (1) CN1230222A (et)
AU (1) AU4619297A (et)
BG (1) BG103238A (et)
BR (1) BR9711475A (et)
CA (1) CA2265467A1 (et)
CZ (1) CZ73499A3 (et)
DE (1) DE19637518A1 (et)
EA (1) EA199900253A1 (et)
EE (1) EE9900092A (et)
HU (1) HUP9904110A3 (et)
IL (1) IL128746A0 (et)
IS (1) IS4987A (et)
NO (1) NO991227L (et)
PL (1) PL332417A1 (et)
SK (1) SK34099A3 (et)
TR (1) TR199900500T2 (et)
WO (1) WO1998011212A1 (et)
ZA (1) ZA978220B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
WO1999058669A1 (en) * 1998-05-11 1999-11-18 Axys Pharmaceuticals, Inc. Rhoh genes and their uses
WO2000015785A2 (de) * 1998-09-10 2000-03-23 Winfried Siffert GENVERÄNDERUNG IM GEN FÜR DIE Gβ3-UNTEREINHEIT DES HUMANEN G-PROTEINS
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
AU2001240585A1 (en) * 2000-02-03 2001-08-14 Snip Biotech Gmbh & Co. Kg Use of a mutation in the gene for the beta3-subunit of human g-protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
BR9711475A (pt) 1999-08-24
AU4619297A (en) 1998-04-02
EA199900253A1 (ru) 1999-10-28
HUP9904110A2 (en) 2000-07-28
TR199900500T2 (xx) 1999-06-21
CN1230222A (zh) 1999-09-29
IL128746A0 (en) 2000-01-31
JP2001501811A (ja) 2001-02-13
EP0931145A1 (de) 1999-07-28
BG103238A (bg) 2000-06-30
SK34099A3 (en) 2000-05-16
PL332417A1 (en) 1999-09-13
ZA978220B (en) 1999-03-12
IS4987A (is) 1999-02-26
NO991227D0 (no) 1999-03-12
KR20000036058A (ko) 2000-06-26
HUP9904110A3 (en) 2001-09-28
WO1998011212A1 (de) 1998-03-19
CA2265467A1 (en) 1998-03-19
US6251853B1 (en) 2001-06-26
DE19637518A1 (de) 1998-04-09
NO991227L (no) 1999-03-12
CZ73499A3 (cs) 1999-07-14

Similar Documents

Publication Publication Date Title
EE05538B1 (et) Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine
BR9708400A (pt) Composição sua preparação e uso
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
ID16224A (id) Bikunin manusia
ATE259241T1 (de) Wässrige peptidzubereitung
NO985464D0 (no) Konsentrert antistoffpreparat
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
EE9900014A (et) Erütromütsiinid ja nende valmistamise protsess
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
ID17860A (id) Komposisi vaksin
EE200000094A (et) Uued plokk-kopolümeerid ja nende saamine
DE59707298D1 (de) Desodorierende zubereitungen
FI963334A0 (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
FI951726A0 (fi) Boronihappopeptidijohdannaisia, niiden valmistus ja käyttö synteesivälituotteina
DK0826679T3 (da) Naphthylforbindelser og -præparater
EE9900092A (et) PTX-tundlikud G-valgud, nende valmistamine ja kasutamine
NO975938D0 (no) Anti-fedme proteiner
NO993354L (no) Voksholdige preparater
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
NO983378D0 (no) Str°mretterutrustning
KR960010685A (ko) 펩티드 및 그 용도
EE9800085A (et) 3,5-difluoropüridiinid, nende valmistamismeetod, herbitsiidne kompositsioon ja nende kasutamine
DE29611773U1 (de) Häcksler
DE29603764U1 (de) Häcksler